The effectiveness of diffusion kurtosis imaging metrics for distinguishing between brainstem glioma and cerebellar...

Area of Science:

• Neuroimaging
• Oncology
• Pediatric Radiology

Background:

• Distinguishing cerebellar medulloblastoma from brainstem glioma is clinically significant in pediatric oncology.
• Accurate differentiation is crucial for appropriate treatment planning and patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of Diffusion Kurtosis Imaging (DKI) metrics in differentiating pediatric cerebellar medulloblastomas from brainstem gliomas.
• To determine if DKI parameters can serve as reliable biomarkers for distinguishing these two common pediatric brain tumors.

Main Methods:

• A prospective study involving 70 pediatric patients diagnosed with either brainstem glioma (n=30) or cerebellar medulloblastoma (n=40).
• Brain magnetic resonance imaging (MRI) including DKI was performed on all participants.
• Tumor Kurtosis values and the ratio of tumor to normal parenchyma Kurtosis (rKurtosis) were analyzed and compared between groups using statistical tests (Mann-Whitney U).
• Receiver operating characteristic (ROC) curve analysis was employed to determine diagnostic cutoff values, sensitivity, specificity, and Area Under the Curve (AUC).

Main Results:

• Cerebellar medulloblastomas exhibited significantly higher Kurtosis and rKurtosis values compared to brainstem gliomas (p < 0.05).
• A Kurtosis cutoff of 0.91 and an rKurtosis cutoff of 0.90 demonstrated high diagnostic performance.
• These cutoffs achieved 100% sensitivity, 96.7% specificity, and an AUC of 0.990 for differentiating between the two tumor types.

Conclusions:

• Diffusion Kurtosis Imaging (DKI) provides valuable quantitative metrics for differentiating pediatric cerebellar medulloblastoma from brainstem glioma.
• DKI-derived Kurtosis and rKurtosis values are promising non-invasive biomarkers for improving diagnostic accuracy in pediatric neuro-oncology.
• The findings suggest that DKI can be a powerful tool in the diagnostic workup of pediatric brain tumors, potentially guiding treatment decisions.